TSXV:GSD (Canada)
Â
Registered Shs Subord Vtg
C$
0.18
(0%)
Jun 3
Business Description
Devonian Health Group Inc
NAICS : 325412
SIC : 3741
ISIN : CA2518341078
Share Class Description:
TSXV:GSD: Registered Shs Subord VtgDescription
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.69 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.18 | |||||
| Beneish M-Score | 0.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.2 | |||||
| 3-Year EBITDA Growth Rate | 9.1 | |||||
| 3-Year EPS without NRI Growth Rate | 18.1 | |||||
| 3-Year FCF Growth Rate | -4.6 | |||||
| 3-Year Book Growth Rate | -4.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 1.24 | |||||
| 9-Day RSI | 8.86 | |||||
| 14-Day RSI | 18.96 | |||||
| 6-1 Month Momentum % | 100 | |||||
| 12-1 Month Momentum % | -9.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | |||||
| Quick Ratio | 1.11 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 20.51 | |||||
| Days Sales Outstanding | 65.88 | |||||
| Days Payable | 115.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.5 | |||||
| Shareholder Yield % | 3.52 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.9 | |||||
| Operating Margin % | -79.85 | |||||
| Net Margin % | -85.08 | |||||
| FCF Margin % | -59.76 | |||||
| ROE % | -30.38 | |||||
| ROA % | -22.8 | |||||
| ROIC % | -25.54 | |||||
| ROC (Joel Greenblatt) % | -145.57 | |||||
| ROCE % | -27.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5 | |||||
| PB Ratio | 1.94 | |||||
| Price-to-Tangible-Book | 8.75 | |||||
| EV-to-EBIT | -6.38 | |||||
| EV-to-EBITDA | -7.16 | |||||
| EV-to-Revenue | 4.99 | |||||
| EV-to-FCF | -8.34 | |||||
| Earnings Yield (Greenblatt) % | -15.67 | |||||
| FCF Yield % | -11.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Devonian Health Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 5.032 | ||
| EPS (TTM) (C$) | -0.029 | ||
| Beta | 0 | ||
| Volatility % | 98.42 | ||
| 14-Day RSI | 18.96 | ||
| 14-Day ATR (C$) | 0.003226 | ||
| 20-Day SMA (C$) | 0.1975 | ||
| 12-1 Month Momentum % | -9.09 | ||
| 52-Week Range (C$) | 0.11 - 0.275 | ||
| Shares Outstanding (Mil) | 148.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Devonian Health Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Devonian Health Group Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Devonian Health Group Inc Frequently Asked Questions
What is Devonian Health Group Inc(TSXV:GSD)'s stock price today?
The current price of TSXV:GSD is C$0.18. The 52 week high of TSXV:GSD is C$0.28 and 52 week low is C$0.11.
When is next earnings date of Devonian Health Group Inc(TSXV:GSD)?
The next earnings date of Devonian Health Group Inc(TSXV:GSD) is .
Does Devonian Health Group Inc(TSXV:GSD) pay dividends? If so, how much?
Devonian Health Group Inc(TSXV:GSD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers